Browse
Browse and Search
Search
Explore more content
12885_2024_11916_MOESM1_ESM.
docx
(26.77 kB)
File info
This item contains files with download restrictions
Fullscreen
Additional file 1 of Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis
Cite
Download
(26.77 kB)
Share
Embed
journal contribution
posted on 2024-02-09, 04:40
authored by
Mingye Zhao
,
Taihang Shao
,
Hanqiao Shao
,
Caicun Zhou
,
Wenxi Tang
Additional file 1.
Funding
General Program of National Natural Science Foundation of China
History
Usage metrics
Categories
Medicine
Pharmacology
Cancer
Science Policy
Mental Health
Keywords
ALK-inhibitors
Network meta-analysis
Non-small-cell lung cancer
Efficacy
Safety
Quality of life
Licence
CC BY + CC0
Exports
Select an option
RefWorks
RefWorks
BibTeX
BibTeX
Ref. manager
Ref. manager
Endnote
Endnote
DataCite
DataCite
NLM
NLM
DC
DC